Bipolar disorder staging and the impact it has on its management: an update

References

• McIntyre RS, Berk M, Brietzke E, et al. Bipolar disorders. Lancet. 2020;396(10265):1841–1856. doi: 10.1016/S0140-6736(20)31544-0
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–251. doi: 10.1001/archgenpsychiatry.2011.12
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Al-Hamzawi A, Alonso J, et al. Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries. Lancet Psychiatry. 2023;10(9):668–681. doi: 10.1016/S2215-0366(23)00193-1
   PubMed Web of Science ®Google Scholar
• Cardoso G, Xavier M, Vilagut G, et al. Days out of role due to common physical and mental conditions in Portugal: results from the WHO world mental health survey. BJPsych Open. 2017 [cited 2017 Feb 7];3(1):15–21. doi: 10.1192/bjpo.bp.115.002402
   PubMed Web of Science ®Google Scholar
• Goodwin F, Jamison K. Manic-depressive illness: bipolar disorders and recurrent depression. 2nd ed. (NY): Oxford University Press; 2007.
   Google Scholar
• Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9(7):671–678. doi: 10.1111/j.1399-5618.2007.00484.x
   PubMed Web of Science ®Google Scholar
• Berk M, Berk L, Dodd S, et al. Stage managing bipolar disorder. Bipolar Disord. 2014;16(5):471–477. doi: 10.1111/bdi.12099
   PubMed Web of Science ®Google Scholar
• Grewal S, McKinlay S, Kapczinski F, et al. Biomarkers of neuroprogression and late staging in bipolar disorder: a systematic review. Aust N Z J Psychiatry. 2023;57(3):328–343. doi: 10.1177/00048674221091731
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Berk M. Staging in bipolar disorder: one step closer to precision psychiatry. Braz J Psychiatry. 2017;39(2):88–89. doi: 10.1590/1516-4446-2017-3902
   PubMedGoogle Scholar
• Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res. 2011;19(2):279–285. doi: 10.1007/s12640-010-9197-8
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Magalhães PV, Balanzá-Martinez V, et al. Staging systems in bipolar disorder: an international society for bipolar disorders task force report. Acta Psychiatr Scand. 2014;130(5):354–363. doi: 10.1111/acps.12305
   PubMed Web of Science ®Google Scholar
• Muneer A. The neurobiology of bipolar disorder: an integrated approach. Chonnam Med J. 2016;52(1):18–37. doi: 10.4068/cmj.2016.52.1.18
   PubMedGoogle Scholar
• Salagre E, Dodd S, Aedo A, et al. Toward precision psychiatry in bipolar disorder: Staging 2.0. Front Psychiatry. 2018 [cited 2018 Nov 29];9:641. doi: 10.3389/fpsyt.2018.00641
   PubMed Web of Science ®Google Scholar
• Suppes T, Dennehy EB, Gibbons EW. The longitudinal course of bipolar disorder. J Clin Psychiatry. 2000;61(Suppl 9):23–30.
   PubMedGoogle Scholar
• Passos IC, Mwangi B, Vieta E, et al. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134(2):91–103. doi: 10.1111/acps.12581
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 2008;10(1 Pt 2):163–178. doi: 10.1111/j.1399-5618.2007.00561.x
   PubMed Web of Science ®Google Scholar
• Post RM. How to prevent the malignant progression of bipolar disorder. Braz J Psychiatry. 2020;42(5):552–557. doi: 10.1590/1516-4446-2020-0874
   PubMedGoogle Scholar
• Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–817. doi: 10.1016/j.neubiorev.2010.10.001
   PubMed Web of Science ®Google Scholar
• Tsapekos D, Strawbridge R, Cella M, et al. Cognitive impairment in euthymic patients with bipolar disorder: Prevalence estimation and model selection for predictors of cognitive performance. J Affect Disord. 2021;294:497–504. doi: 10.1016/j.jad.2021.07.036
   PubMed Web of Science ®Google Scholar
• Knežević V, Nedić A. Influence of misdiagnosis on the course of bipolar disorder. Eur Rev Med Pharmacol Sci. 2013;17(11):1542–1545.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. 2001;158(8):1265–1270. doi: 10.1176/appi.ajp.158.8.1265
   PubMed Web of Science ®Google Scholar
• McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420–426. doi: 10.1176/appi.ajp.158.3.420
   PubMed Web of Science ®Google Scholar
• Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67(1):1–8. doi: 10.1097/01.psy.0000151489.36347.18
   PubMed Web of Science ®Google Scholar
• Chan JKN, Tong CHY, Wong CSM, et al. Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta-analysis. Br J Psychiatry. 2022;221(3):567–576. doi: 10.1192/bjp.2022.19
   PubMed Web of Science ®Google Scholar
• Pompili M, Gonda X, Serafini G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013;15(5):457–490. doi: 10.1111/bdi.12087
   PubMed Web of Science ®Google Scholar
• Schaffer A, Isometsä ET, Tondo L, et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the international society for bipolar disorders task force on suicide in bipolar disorder. Aust N Z J Psychiatry. 2015;49(9):785–802. doi: 10.1177/0004867415594427
   PubMed Web of Science ®Google Scholar
• Plans L, Barrot C, Nieto E, et al. Association between completed suicide and bipolar disorder: a systematic review of the literature. J Affect Disord. 2019;242:111–122. doi: 10.1016/j.jad.2018.08.054
   PubMed Web of Science ®Google Scholar
• Goffin KC, Dell’osso B, Miller S, et al. Different characteristics associated with suicide attempts among bipolar I versus bipolar II disorder patients. J Psychiatr Res. 2016;76:94–100. doi: 10.1016/j.jpsychires.2016.02.006
   PubMed Web of Science ®Google Scholar
• Cremaschi L, Dell’osso B, Vismara M, et al. Onset polarity in bipolar disorder: a strong association between first depressive episode and suicide attempts. J Affect Disord. 2017;209:182–187. doi: 10.1016/j.jad.2016.11.043
   PubMed Web of Science ®Google Scholar
• Altamura AC, Dell’osso B, Berlin HA, et al. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2010;260(5):385–391. doi: 10.1007/s00406-009-0085-2
   PubMed Web of Science ®Google Scholar
• Kessing LV, Vradi E, Rs M, et al. Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord. 2015;180:142–147. doi: 10.1016/j.jad.2015.03.027
   PubMed Web of Science ®Google Scholar
• Firth J, Siddiqi N, Koyanagi A, et al. The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019;6(8):675–712. doi: 10.1016/S2215-0366(19)30132-4
   PubMed Web of Science ®Google Scholar
• Aguglia A, Salvi V, Amerio A, et al. Number of episodes and duration of illness associated with hypertension and 10-year cardiovascular risk in patients with bipolar disorder type I. Psychiatry Res. 2022;308:114344. doi: 10.1016/j.psychres.2021.114344
   PubMed Web of Science ®Google Scholar
• Van Rheenen TE, Lewandowski KE, Bauer IE, et al. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: an overview of evidence. Bipolar Disord. 2020;22(1):13–27. doi: 10.1111/bdi.12821
   PubMed Web of Science ®Google Scholar
• Gordovez FJA, McMahon FJ. The genetics of bipolar disorder. Mol Psychiatry. 2020;25(3):544–559. doi: 10.1038/s41380-019-0634-7
   PubMed Web of Science ®Google Scholar
• Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381(9878):1654–1662. doi: 10.1016/S0140-6736(13)60855-7
   PubMed Web of Science ®Google Scholar
• Stahl EA, Breen G, Forstner AJ, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51(5):793–803. doi: 10.1038/s41588-019-0397-8
   PubMed Web of Science ®Google Scholar
• Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858–873. doi: 10.1016/j.neubiorev.2007.04.003
   PubMed Web of Science ®Google Scholar
• Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011b;13(1):87–98. doi: 10.1111/j.1399-5618.2011.00889.x
   PubMed Web of Science ®Google Scholar
• Serafini G, Pardini M, Monacelli F, et al. Neuroprogression as an illness trajectory in bipolar disorder: a selective review of the current literature. Brain Sci. 2021 [cited 2021 Feb 23];11(2):276. doi: 10.3390/brainsci11020276
   PubMed Web of Science ®Google Scholar
• Strakowski SM, DelBello MP, Zimmerman ME, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002;159(11):1841–1847. doi: 10.1176/appi.ajp.159.11.1841
   PubMed Web of Science ®Google Scholar
• Moorhead TW, McKirdy J, Sussmann JE, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry. 2007;62(8):894–900. doi: 10.1016/j.biopsych.2007.03.005
   PubMed Web of Science ®Google Scholar
• Gulseren S, Gurcan M, Gulseren L, et al. T2 hyperintensities in bipolar patients and their healthy siblings. Arch Med Res. 2006;37(1):79–85. doi: 10.1016/j.arcmed.2005.04.009
   PubMed Web of Science ®Google Scholar
• Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65(9):1017–1032. doi: 10.1001/archpsyc.65.9.1017
   PubMed Web of Science ®Google Scholar
• Gong J, Wang J, Chen P, et al. Large-scale network abnormality in bipolar disorder: a multimodal meta-analysis of resting-state functional and structural magnetic resonance imaging studies. J Affect Disord. 2021;292:9–20. doi: 10.1016/j.jad.2021.05.052
   PubMed Web of Science ®Google Scholar
• Cattarinussi G, Di Giorgio A, Wolf RC, et al. Neural signatures of the risk for bipolar disorder: a meta-analysis of structural and functional neuroimaging studies. Bipolar Disord. 2019;21(3):215–227. doi: 10.1111/bdi.12720
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Molendijk ML, Köhler CA, et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. 2015 [cited 2015 Nov 30];13(1):289. doi: 10.1186/s12916-015-0529-7
   PubMedGoogle Scholar
• D’Addario C, Dell’osso B, Palazzo MC, et al. Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology. 2012;37(7):1647–1655. doi: 10.1038/npp.2012.10
   PubMed Web of Science ®Google Scholar
• D’Addario C, Dell’osso B, Galimberti D, et al. Epigenetic modulation of BDNF gene in patients with major depressive disorder. Biol Psychiatry. 2013;73(2):e6–e7. doi: 10.1016/j.biopsych.2012.07.009
   PubMed Web of Science ®Google Scholar
• Dell’osso B, D’Addario C, Carlotta Palazzo M, et al. Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J Affect Disord. 2014;166:330–333. doi: 10.1016/j.jad.2014.05.020
   PubMed Web of Science ®Google Scholar
• Nassan M, Veldic M, Winham S, et al. Methylation of brain derived neurotrophic factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder. J Affect Disord. 2020;267:96–102. doi: 10.1016/j.jad.2020.02.002
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, McIntyre RS. Bipolar disorder and inflammation. Psychiatr Clin North Am. 2016;39(1):125–137. doi: 10.1016/j.psc.2015.09.006
   PubMed Web of Science ®Google Scholar
• Tatay-Manteiga A, Balanzá-Martínez V, Bristot G, et al. Clinical staging and serum cytokines in bipolar patients during euthymia. Prog Neuropsychopharmacol Biol Psychiatry. 2017;77:194–201. doi: 10.1016/j.pnpbp.2017.04.028
   PubMed Web of Science ®Google Scholar
• Lima Giacobbo B, Doorduin J, Klein HC, et al. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol. 2019;56(5):3295–3312. doi: 10.1007/s12035-018-1283-6
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Scully P, Scott LV, et al. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006;90(2–3):263–267. doi: 10.1016/j.jad.2005.11.015
   PubMed Web of Science ®Google Scholar
• Siwek M, Sowa-Kućma M, Styczeń K, et al. Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder. Mol Neurobiol. 2017;54(8):5883–5893. doi: 10.1007/s12035-016-0124-8
   PubMed Web of Science ®Google Scholar
• Anderson G, Maes M. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep. 2015;17(2):8. doi: 10.1007/s11920-014-0541-1
   PubMed Web of Science ®Google Scholar
• Jiménez-Fernández S, Gurpegui M, Garrote-Rojas D, et al. Oxidative stress parameters and antioxidants in patients with bipolar disorder: results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disord. 2021;23(2):117–129. doi: 10.1111/bdi.12980
   PubMed Web of Science ®Google Scholar
• Savas HA, Gergerlioglu HS, Armutcu F, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry. 2006;7(1):51–55. doi: 10.1080/15622970510029993
   PubMed Web of Science ®Google Scholar
• Gergerlioglu HS, Savas HA, Bulbul F, et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment [published correction appears in prog neuropsychopharmacol biol psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. [2007 Aug 15];31(6):697–702. doi: 10.1016/j.pnpbp.2006.12.020
   PubMedGoogle Scholar
• Andreazza AC, Kauer-Sant’anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008;111(2–3):135–144. doi: 10.1016/j.jad.2008.04.013
   PubMed Web of Science ®Google Scholar
• Kaczmarek KT, Protokowicz K, Kaczmarek L. Matrix metalloproteinase-9: A magic drug target in neuropsychiatry? J Neurochem. [cited 2023 Oct 4]. doi: 10.1111/jnc.15976
   Web of Science ®Google Scholar
• Beroun A, Mitra S, Michaluk P, et al. MMPs in learning and memory and neuropsychiatric disorders. Cell Mol Life Sci. 2019;76(16):3207–3228. doi: 10.1007/s00018-019-03180-8
   PubMed Web of Science ®Google Scholar
• Reininghaus EZ, Lackner N, Birner A, et al. Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder. Bipolar Disord. 2016;18(2):155–163. doi: 10.1111/bdi.12380
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Remlinger-Molenda A, Czech-Kucharska A, et al. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. J Affect Disord. 2013;146(2):286–289. doi: 10.1016/j.jad.2012.07.019
   PubMed Web of Science ®Google Scholar
• Jonsson BH, Orhan F, Bruno S, et al. Serum concentration of zinc is elevated in clinically stable bipolar disorder patients. Brain Behav. 2022;12(1):e2472. doi: 10.1002/brb3.2472
   PubMed Web of Science ®Google Scholar
• Siwek M, Sowa-Kućma M, Styczeń K, et al. Decreased serum zinc concentration during depressive episode in patients with bipolar disorder. J Affect Disord. 2016;190:272–277. doi: 10.1016/j.jad.2015.10.026
   PubMed Web of Science ®Google Scholar
• Siwek M, Styczeń K, Sowa-Kućma M, et al. The serum concentration of copper in bipolar disorder. Stężenie miedzi w surowicy w chorobie afektywnej dwubiegunowej. Psychiatr Pol. 2017;51(3):469–481. doi: 10.12740/PP/OnlineFirst/65250
   PubMed Web of Science ®Google Scholar
• Kupka R, Duffy A, Scott J, et al. Consensus on nomenclature for clinical staging models in bipolar disorder: a narrative review from the international society for bipolar disorders (ISBD) staging task force. Bipolar Disord. 2021;23(7):659–678. doi: 10.1111/bdi.13105
   PubMed Web of Science ®Google Scholar
• Berk M, Post R, Ratheesh A, et al. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. 2017;16(3):236–244. doi: 10.1002/wps.20441
   PubMed Web of Science ®Google Scholar
• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi: 10.1016/S0140-6736(15)00241-X
   PubMed Web of Science ®Google Scholar
• Joyce K, Thompson A, Marwaha S. Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord. 2016;4(1):19. doi: 10.1186/s40345-016-0060-6
   PubMed Web of Science ®Google Scholar
• Chia MF, Cotton S, Filia K, et al. Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder? J Affect Disord. 2019;257:669–677. doi: 10.1016/j.jad.2019.07.062
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Firth J, Vieta EBD, et al. Bipolar Disorder. N Engl J Med. 2020;383(1):58–66. doi: 10.1056/NEJMra1906193
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170. doi: 10.1111/bdi.12609
   PubMed Web of Science ®Google Scholar
• Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry. 2010;71(12):1689–1695. doi: 10.4088/JCP.10m06347yel
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864–872. doi: 10.4088/JCP.08m04994yel
   PubMed Web of Science ®Google Scholar
• Scott S, O’Connor TG. An experimental test of differential susceptibility to parenting among emotionally-dysregulated children in a randomized controlled trial for oppositional behavior. J Child Psychol Psychiatr. 2012;53(11):1184–1193. doi: 10.1111/j.1469-7610.2012.02586.x
   PubMed Web of Science ®Google Scholar
• Ketter TA, Nasrallah HA, Fagiolini A. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacol Bull. 2006;39(1):120–146.
   PubMedGoogle Scholar
• Fiorillo A, Sampogna G, Albert U, et al. Facts and myths about the use of lithium for bipolar disorder in routine clinical practice: an expert consensus paper. Ann Gen Psychiatry. 2023 [cited 2023 Dec 6];22(1):50. doi: 10.1186/s12991-023-00481-y
   PubMed Web of Science ®Google Scholar
• Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry. 2014;205(3):214–220. doi: 10.1192/bjp.bp.113.142802
   PubMed Web of Science ®Google Scholar
• Ratheesh A, Hett D, Ramain J, et al. A systematic review of interventions in the early course of bipolar disorder I or II: a report of the international society for bipolar disorders taskforce on early intervention. Int J Bipolar Disord. 2023 [cited 2023 Jan 3];11(1):1. doi: 10.1186/s40345-022-00275-3
   PubMed Web of Science ®Google Scholar
• Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health. 2010;19(2):113–126. doi: 10.3109/09638230903469111
   PubMed Web of Science ®Google Scholar
• Conus P, Macneil C, McGorry PD. Public health significance of bipolar disorder: implications for early intervention and prevention. Bipolar Disord. 2014;16(5):548–556. doi: 10.1111/bdi.12137
   PubMed Web of Science ®Google Scholar
• van der Markt, A, Klumpers UM, Draisma S, et al. Testing a clinical staging model for bipolar disorder using longitudinal life chart data. Bipolar Disord. 2019;21(3):228–234. doi: 10.1111/bdi.12727
   PubMed Web of Science ®Google Scholar
• Duffy A, Carlson GA. How does A developmental perspective inform us about the early natural history of bipolar disorder? J Can Acad Child Adolesc Psychiatry. 2013;22(1):6–12.
   PubMedGoogle Scholar
• Zivanovic O, Nedic A. Kraepelin’s concept of manic-depressive insanity: one hundred years later. J Affect Disord. 2012;137(1–3):15–24. doi: 10.1016/j.jad.2011.03.032
   PubMed Web of Science ®Google Scholar
• Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand. 1993;87(4):225–230. doi: 10.1111/j.1600-0447.1993.tb03362.x
   PubMed Web of Science ®Google Scholar
• McGorry P, Keshavan M, Goldstone S, et al. Biomarkers and clinical staging in psychiatry. World Psychiatry. 2014;13(3):211–223. doi: 10.1002/wps.20144
   PubMed Web of Science ®Google Scholar
• McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–622. doi: 10.1080/j.1440-1614.2006.01860.x
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dias VV, Kauer-Sant’anna M, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(7):957–966. doi: 10.1586/ern.09.31
   PubMed Web of Science ®Google Scholar
• Kupka RW, Hillegers MH. Stagering en profilering bij bipolaire stoornissen [Staging and profiling in bipolar disorders]. Tijdschr Psychiatr. 2012;54(11):949–956.
   PubMedGoogle Scholar
• Duffy A. Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can J Psychiatry. 2014;59(12):659–666. doi: 10.1177/070674371405901208
   PubMed Web of Science ®Google Scholar
• Kessing LV, Agerbo E, Mortensen PB. Major stressful life events and other risk factors for first admission with mania. Bipolar Disord. 2004;6(2):122–129. doi: 10.1111/j.1399-5618.2004.00102.x
   PubMed Web of Science ®Google Scholar
• Kessing LV, Mortensen PB, Bolwig TG. Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord. 1998;47(1–3):31–39. doi: 10.1016/s0165-0327(97)00081-5
   PubMed Web of Science ®Google Scholar
• Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68(2–3):167–181. doi: 10.1016/s0165-0327(01)00377-9
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Calabrese JR, et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156(8):1264–1266. doi: 10.1176/ajp.156.8.1264
   PubMed Web of Science ®Google Scholar
• Martínez-Arán A, Vieta E, Colom F, et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom. 2005;74(5):295–302. doi: 10.1159/000086320
   PubMed Web of Science ®Google Scholar
• McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840(1):33–44. doi: 10.1111/j.1749-6632.1998.tb09546.x Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675–692. doi: 10.1016/j.neubiorev.2007.10.005.
   PubMed Web of Science ®Google Scholar
• Rosa AR, Frey BN, Andreazza AC, et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett. 2006;407(2):146–150. doi: 10.1016/j.neulet.2006.08.026
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–458. doi: 10.1017/S1461145708009310
   PubMed Web of Science ®Google Scholar
• Bonnín CM, Martínez-Arán A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1–2):156–160. doi: 10.1016/j.jad.2009.05.014
   PubMed Web of Science ®Google Scholar
• van der Markt A, Klumpers UMH, Dols A, et al. Exploring the clinical utility of two staging models for bipolar disorder. Bipolar Disord. 2020;22(1):38–45. doi: 10.1111/bdi.12825
   PubMed Web of Science ®Google Scholar
• de la Fuente-Tomás L, Sierra P, Sanchez-Autet M, et al. A clinical staging model for bipolar disorder: longitudinal approach. Transl Psychiatry. 2020 [cited 2020 Jan 29];10(1):45. doi: 10.1038/s41398-020-0718-9
   PubMed Web of Science ®Google Scholar
• Macellaro M, Girone N, Cremaschi L, et al. Staging models applied in a sample of patients with bipolar disorder: results from a retrospective cohort study. J Affect Disord. 2023;323:452–460. doi: 10.1016/j.jad.2022.11.081
   PubMed Web of Science ®Google Scholar
• Saraf G, Moazen-Zadeh E, Pinto JV, et al. Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials. Lancet Psychiatry. 2021;8(1):64–75. doi: 10.1016/S2215-0366(20)30188-7
   PubMed Web of Science ®Google Scholar
• Jauhar S, Ratheesh A, Davey C, et al. The case for improved care and provision of treatment for people with first-episode mania [published correction appears in lancet psychiatry. Lancet Psychiatry. 2020 Jul;7(7):869–876. doi: 10.1016/S2215-0366(19)30082-3
   Google Scholar
• Parker G. Staging the bipolar disorders: are early stages at too early a stage for intervention? Bipolar Disord. 2022;24(8):784–787. doi: 10.1111/bdi.13256
   PubMed Web of Science ®Google Scholar
• Jan Z, Ai-Ansari N, Mousa O, et al. The role of machine learning in diagnosing bipolar disorder: scoping review. J Med Internet Res. 2021 [cited 2021 Nov 19];23(11):e29749. doi: 10.2196/29749
   PubMed Web of Science ®Google Scholar
• Colombo F, Calesella F, Mazza MG, et al. Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;135:104552. doi: 10.1016/j.neubiorev.2022.104552
   PubMed Web of Science ®Google Scholar